(Q43184911)

15 November 2017

title

The impact of liver fat vs visceral fat in determining categories of prediabetes (English)

1 reference

15 November 2017

6

1 reference

15 November 2017

2

J Machann

1 reference

15 November 2017

3

F Schick

1 reference

15 November 2017

4

A Fritsche

1 reference

15 November 2017

Konstantinos Kantartzis

series ordinal

1

object named as

K Kantartzis

1 reference

15 November 2017

5

H-U Häring

1 reference

15 November 2017

publication date

23 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

53

1 reference

15 November 2017

issue

5

1 reference

15 November 2017

page(s)

882-889

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-010-1663-6

15 November 2017

exact match

0 references

cites work

Adipose tissue-derived factors: impact on health and disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1663-6

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1663-6

Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans

21 January 2018

1 reference

12 December 2020

Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.

1 reference

12 December 2020

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study

1 reference

12 December 2020

The Relationships of Plasma Adiponectin with a Favorable Lipid Profile, Decreased Inflammation, and Less Ectopic Fat Accumulation Depend on Adiposity

1 reference

12 December 2020

Plasma fetuin-A levels and the risk of type 2 diabetes

1 reference

12 December 2020

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.

1 reference

12 December 2020

Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study

1 reference

12 December 2020

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

12 December 2020

Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study

1 reference

12 December 2020

Review: The role of insulin resistance in nonalcoholic fatty liver disease

1 reference

12 December 2020

Identification and characterization of metabolically benign obesity in humans

1 reference

12 December 2020

Abdominal obesity and metabolic syndrome

1 reference

12 December 2020

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance

1 reference

12 December 2020

Variations inPPARDDetermine the Change in Body Composition during Lifestyle Intervention: A Whole-Body Magnetic Resonance Study

1 reference

12 December 2020

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

1 reference

12 December 2020

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

1 reference

12 December 2020

Fatty liver: a novel component of the metabolic syndrome

1 reference

12 December 2020

Metabolically healthy but obese individuals

1 reference

12 December 2020

Predicting future cardiovascular disease: do we need the oral glucose tolerance test?

1 reference

12 December 2020

Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypes

1 reference

12 December 2020

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

12 December 2020

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

1 reference

12 December 2020

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

1 reference

12 December 2020

Ectopic lipids and organ function

1 reference

12 December 2020

Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men

1 reference

12 December 2020

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

1 reference

12 December 2020

Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat.

1 reference

12 December 2020

The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group.

1 reference

12 December 2020

Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?

1 reference

12 December 2020

Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetes

1 reference

12 December 2020

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

1 reference

12 December 2020

Follow-up report on the diagnosis of diabetes mellitus

1 reference

12 December 2020

The association between plasma adiponectin and insulin sensitivity in humans depends on obesity

1 reference

12 December 2020

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

1 reference

12 December 2020

Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response

1 reference

12 December 2020

The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature

1 reference

12 December 2020

Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

1 reference

12 December 2020

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

1 reference

12 December 2020

Fetuin-A and incident diabetes mellitus in older persons

1 reference

12 December 2020

Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose

1 reference

12 December 2020

Impaired fasting glucose and impaired glucose tolerance: implications for care

1 reference

12 December 2020

Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study

1 reference

12 December 2020

Plasma glucose regulation and mortality in pima Indians

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

12 December 2020

Causes and metabolic consequences of Fatty liver

1 reference

12 December 2020

10.1007/S00125-010-1663-6

Identifiers

DOI

1 reference

15 November 2017

1 reference